NZ211030A - Passive heterologous immunisation compositions based on antibodies from pre-immunised fowls and/or bovids - Google Patents

Passive heterologous immunisation compositions based on antibodies from pre-immunised fowls and/or bovids

Info

Publication number
NZ211030A
NZ211030A NZ211030A NZ21103085A NZ211030A NZ 211030 A NZ211030 A NZ 211030A NZ 211030 A NZ211030 A NZ 211030A NZ 21103085 A NZ21103085 A NZ 21103085A NZ 211030 A NZ211030 A NZ 211030A
Authority
NZ
New Zealand
Prior art keywords
antibody
antigen
bovid
milk
fowl
Prior art date
Application number
NZ211030A
Other languages
English (en)
Inventor
R J Stolle
L R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of NZ211030A publication Critical patent/NZ211030A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507Comprising a combination of two or more separate antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
NZ211030A 1984-02-07 1985-02-04 Passive heterologous immunisation compositions based on antibodies from pre-immunised fowls and/or bovids NZ211030A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57780484A 1984-02-07 1984-02-07
US06/622,130 US4748018A (en) 1984-02-07 1984-06-19 Method of passive immunization of mammals using avian antibody

Publications (1)

Publication Number Publication Date
NZ211030A true NZ211030A (en) 1989-11-28

Family

ID=27077340

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ211030A NZ211030A (en) 1984-02-07 1985-02-04 Passive heterologous immunisation compositions based on antibodies from pre-immunised fowls and/or bovids

Country Status (12)

Country Link
US (1) US4748018A (forum.php)
EP (2) EP0395120B1 (forum.php)
JP (6) JP2548115B2 (forum.php)
AT (1) ATE135016T1 (forum.php)
CA (3) CA1275044A (forum.php)
DE (1) DE3504221C2 (forum.php)
DK (2) DK166905B1 (forum.php)
GR (1) GR850323B (forum.php)
HK (1) HK1000183A1 (forum.php)
IE (1) IE64365B1 (forum.php)
IL (1) IL74155A (forum.php)
NZ (1) NZ211030A (forum.php)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
US5932250A (en) * 1982-06-03 1999-08-03 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
EP0225254B1 (en) * 1985-11-25 1994-03-16 Ghen Corporation Specific antibody-containing substance from eggs and method of production and use thereof
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
US5565550A (en) * 1987-05-04 1996-10-15 Dana Farber Cancer Institute Antibodies to ICAM-2, and fragments thereof
JP2641228B2 (ja) * 1988-01-22 1997-08-13 鐘紡株式会社 抗体およびそれを有効成分とするう蝕予防剤、並びにこれらの製造方法
US5059419A (en) * 1988-06-09 1991-10-22 Grand Laboratories, Inc. Streptococcus suis antiserum and its use in treating Streptococcus suis infections
JP2689511B2 (ja) * 1988-08-18 1997-12-10 ライオン株式会社 食 品
US6511664B1 (en) 1989-03-09 2003-01-28 Dana Farber Cancer Institute Intercellular adhesion molecule—2 and its binding ligands
DE3924746A1 (de) * 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
US6932968B1 (en) 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
US7005560B1 (en) * 1989-10-27 2006-02-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5196193A (en) * 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
US5958413A (en) * 1990-11-01 1999-09-28 Celltech Limited Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
JP2553445B2 (ja) * 1992-12-17 1996-11-13 同仁医薬化工株式会社 抗体の安定化方法
DK0707485T3 (da) * 1993-05-26 2002-08-26 Dcv Inc Cholesterolsænkende æg, vaccine og fremgangsmåde til fremstilling og anvendelse
US6068862A (en) * 1993-06-30 2000-05-30 Taiyo Kagaku Co., Ltd. Tea-derived feed additive and animal feed containing the same
AU1518595A (en) * 1994-01-14 1995-08-01 Genentech Inc. Antagonists to insulin receptor tyrosine kinase inhibitor
DE69535374T2 (de) 1994-02-09 2007-08-23 Epitopix Llc, Willmar Aktive immunisierung gegen ein siderophores rezeptorprotein
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
CA2196594A1 (en) * 1994-08-05 1996-02-22 Mark E. Cook Use of antibodies to cck to improve feed efficiency
US5814316A (en) * 1994-08-05 1998-09-29 Wisconsin Alumni Research Foundation Compound to mimick a naturally occurring peptide's effect
US5939269A (en) * 1994-12-28 1999-08-17 The Regents Of The University Of California Antagonists to insulin receptor tyrosine kinase inhibitor
AU5431196A (en) * 1995-03-24 1996-10-16 Ophidian Pharmaceuticals Treatment for verotoxin-producing escherichia coli
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
US6413515B1 (en) * 1996-03-12 2002-07-02 Ovogenix Immunpharma Gmbh Avian, vitelline antibodies directed against HIV antigens
US5807551A (en) * 1996-04-01 1998-09-15 Iowa State University Research Foundation, Inc. Method to provide artificial passive immunity in birds
US5725873A (en) * 1996-07-22 1998-03-10 Wisconsin Alumni Research Foundation Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
EP0930891A4 (en) * 1996-10-02 2001-07-04 Ovimmune Inc ORAL ADMINISTRATION OF CHICKEN EGG ANTIBODIES FOR TREATING DISEASES
JP3430853B2 (ja) * 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
JPH10298105A (ja) * 1997-04-23 1998-11-10 Gen Corp:Kk 腸管出血性大腸菌による感染症の予防剤および治療剤
WO1998055143A1 (en) * 1997-06-04 1998-12-10 The Arizona Board Of Regents On Behalf Of The University Of Arizona Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
US6086878A (en) * 1997-08-21 2000-07-11 Dcv, Inc. Method of increasing muscle protein and reducing fat in animals
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
US6395273B1 (en) * 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
JP2000351735A (ja) * 1999-04-09 2000-12-19 Akzo Nobel Nv カンピロバクターワクチン
US7238351B2 (en) * 1999-07-15 2007-07-03 Peter Nash Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
US7241443B1 (en) * 1999-07-15 2007-07-10 Camas Incorporated Immunogen adherence inhibitor and method of making and using same
WO2001013928A1 (en) * 1999-08-24 2001-03-01 Ortho Corporation Co., Ltd. Methods of pasteurizing immune substance containing antiinflammatory factor and utilization thereof
US6706267B1 (en) 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
GB0002386D0 (en) * 2000-02-02 2000-03-22 Novartis Nutrition Ag Therapeutic composition
WO2001072141A2 (en) * 2000-03-24 2001-10-04 Trouw Nutrition Usa Combination of plasma and hyperimmunized products for increased performance of weanlings
EP1353689B9 (en) * 2001-01-03 2006-06-28 Epitopix LLC Immunizing compositions and methods of use
CA2339436A1 (fr) 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
US20030017154A1 (en) * 2001-05-18 2003-01-23 Hunchar Jeffrey G. Method of increasing uniformity in avians
CA2392344A1 (en) * 2001-07-02 2003-01-02 Nutratech Inc. Method for removal of pathogens from a localized environment
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
EP1476184A4 (en) * 2001-12-28 2006-01-04 Camas Inc IMMUNOGENOUS LIABILITY AND METHOD FOR ITS MANUFACTURE AND USE
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
CA2474360A1 (en) * 2002-02-11 2003-08-21 Arkion Life Sciences Llc Purified cytokine inhibitory factor
US20040005327A1 (en) * 2002-05-16 2004-01-08 Subramanian Iyer Immune T-cell stimulation
US6729265B2 (en) * 2002-06-27 2004-05-04 Arkion Life Sciences Llc Supplemented antibody feed to enter the circulating system of newborns
CN1819844B (zh) * 2003-02-19 2012-02-22 彼得·纳什 免疫原粘附抑制剂及其制备和使用方法
US9701737B2 (en) * 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
WO2005003173A1 (en) * 2003-07-07 2005-01-13 Luiz Fernando Mesquita Process of obtaining a freeze-dried complex from mammal gland secretion
ES2395022T3 (es) 2003-09-19 2013-02-07 Epitopix, Llc Polipéptidos de Campylobacter y sus métodos de uso
DE602005026287D1 (de) * 2004-04-16 2011-03-24 Univ Alberta Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie
US8877187B2 (en) * 2005-07-25 2014-11-04 Avianax, Llc Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
WO2007027321A2 (en) * 2005-07-25 2007-03-08 Avianax, Inc. Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
US20070264264A1 (en) * 2005-08-30 2007-11-15 La Belle Associates, Inc. Method and composition for conferring immunity in mammals
CA2521156A1 (en) * 2005-09-16 2007-03-16 John Hare Antibodies as growth promoting agents
EP1790358A1 (en) * 2005-11-23 2007-05-30 Université de Reims Champagne-Ardennes Protein constructs designed for targeting and lysis of cells
EP1998800A2 (en) 2006-01-18 2008-12-10 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
JP4753808B2 (ja) * 2006-06-20 2011-08-24 アサマ化成株式会社 感染症予防食品添加用組成物
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US8282928B2 (en) * 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
ES2599639T3 (es) 2007-07-09 2017-02-02 Nestec S.A. Procedimientos para reducir las alergias causadas por alérgenos ambientales
KR101661946B1 (ko) 2007-08-31 2016-10-05 유니버시티 오브 시카고 스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
WO2010028072A2 (en) * 2008-09-02 2010-03-11 Huan Nguyen Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use
CN102333540B (zh) 2008-10-06 2015-04-22 芝加哥大学 与细菌eap、emp和/或adsa蛋白相关的组合物和方法
EP2414387B1 (en) 2009-04-03 2015-12-16 University Of Chicago Compositions and methods related to protein a (spa) variants
EP3461840A1 (en) 2009-04-27 2019-04-03 Immuron Limited Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of non alcoholic steatohepatitis
US10266585B2 (en) 2009-08-28 2019-04-23 The Board Of Regents Of The Univerity Of Texas System Methods of treating brain injury
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
WO2011140550A2 (en) * 2010-05-07 2011-11-10 Camas Incorporated Immunogen adherence and method of making and using same
EP2588120B1 (en) 2010-07-02 2017-11-15 The University of Chicago Compositions and methods related to protein a (spa) variants
CA2808361A1 (en) 2010-08-17 2012-02-23 Immuron Ltd. Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of inflammatory bowel disease
EP2614074A1 (en) 2010-09-09 2013-07-17 The University of Chicago Methods and compositions involving protective staphylococcal antigens
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN105012950A (zh) * 2010-11-23 2015-11-04 潘瑟里克公司 用于在广谱、未分化或混合临床应用中治疗的组合物和方法
DE102011006781A1 (de) * 2011-04-05 2012-10-11 Mat-Malta Advanced Technologies Limited Antikörperprodukt, umfassend n spezifische Antikörper
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
WO2013025834A2 (en) 2011-08-15 2013-02-21 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein a
JP6251730B2 (ja) 2012-04-26 2017-12-20 ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago 黄色ブドウ球菌(staphylococcusaureus)疾患の間にコアグラーゼ活性を中和する抗体に関連した組成物および方法
US9968668B2 (en) 2012-04-26 2018-05-15 The University Of Chicago Staphylococcal coagulase antigens and methods of their use
US10125373B2 (en) 2013-01-22 2018-11-13 Arizona Board Of Regents On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
AU2014253685B2 (en) 2013-04-19 2019-07-11 Immuron Limited Methods and compositions for the treatment and/or prophylaxis of clostridium difficile associated disease
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
US11246924B2 (en) 2016-04-01 2022-02-15 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
WO2019183500A1 (en) 2018-03-23 2019-09-26 Hung Chiung Yu Coccidioides antigens and methods of their use
US11339387B2 (en) 2018-05-22 2022-05-24 The Government Of The United States Of America As Represented By The Secretary Of Homeland Security Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide
WO2020176637A1 (en) 2019-02-26 2020-09-03 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract
US11701423B2 (en) 2021-03-12 2023-07-18 Lay Sciences, Inc. Hyperimmunized egg product for treatment or prevention of coronavirus infection
WO2022243769A1 (en) 2021-05-17 2022-11-24 Societe Des Produits Nestle Sa Cat food supplements comprising an anti-fel-d1 molecule and an animal digest
WO2023212604A1 (en) 2022-04-27 2023-11-02 Lay Sciences, Inc. Targeted anti-sglt1 avian igy antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes
JP2025516644A (ja) 2022-05-13 2025-05-30 プロディジー バイオテック,インコーポレーテッド ポリペプチド、抗体及びタンパク質の経口送達のための製剤及びその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
US3646193A (en) * 1969-07-25 1972-02-29 Joseph B Michaelson Iga antibody from lacteal fluids
CH590064A5 (forum.php) * 1973-11-28 1977-07-29 Biokema Sa
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
GB2057451B (en) * 1979-09-05 1983-05-05 South African Inventions Immunological preparations comprising egg yolk antibodies
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit

Also Published As

Publication number Publication date
JP2548115B2 (ja) 1996-10-30
JPH08231426A (ja) 1996-09-10
DK53485A (da) 1985-08-08
IL74155A0 (en) 1985-04-30
JPH08231427A (ja) 1996-09-10
DK227190A (da) 1990-09-20
IE64365B1 (en) 1995-07-26
EP0395120A2 (en) 1990-10-31
GR850323B (forum.php) 1985-06-06
CA1276883C (en) 1990-11-27
JP2698778B2 (ja) 1998-01-19
EP0395120B1 (en) 1996-03-06
EP0395120A3 (en) 1990-12-19
EP0152270A2 (en) 1985-08-21
AU3829685A (en) 1985-08-15
AU583808B2 (en) 1989-05-11
JPS60248628A (ja) 1985-12-09
IE850289L (en) 1985-08-07
EP0152270A3 (en) 1988-01-27
DE3504221A1 (de) 1985-12-19
DK166905B1 (da) 1993-08-02
JP2690476B2 (ja) 1997-12-10
JP2698779B2 (ja) 1998-01-19
ATE135016T1 (de) 1996-03-15
DK53485D0 (da) 1985-02-06
CA1276884C (en) 1990-11-27
JP2543633B2 (ja) 1996-10-16
JPH04352729A (ja) 1992-12-07
CA1275044A (en) 1990-10-09
IL74155A (en) 1989-06-30
DE3504221C2 (de) 1994-05-19
DK227190D0 (da) 1990-09-20
EP0152270B1 (en) 1992-09-16
JPH08231425A (ja) 1996-09-10
HK1000183A1 (en) 1998-01-23
JP2723870B2 (ja) 1998-03-09
US4748018A (en) 1988-05-31
JPH08231424A (ja) 1996-09-10

Similar Documents

Publication Publication Date Title
EP0152270B1 (en) Method of passive immunization of mammals using avian and/or bovid antibody and compositions for same
HK1000183B (en) Method of passive immunization of mammals using bovid antibody and compositions for same
Tsubokura et al. Oral administration of antibodies as prophylaxis and therapy in Campylobacter jejuni‐infected chickens
Michael et al. Chicken egg yolk antibodies (IgY) as an alternative to mammalian antibodies
US5753228A (en) Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
Stokes et al. The immune response of mice to bacterial antigens given by mouth
US20070264264A1 (en) Method and composition for conferring immunity in mammals
CA2317813A1 (en) Composition and method for treatment and prevention of arthritis and/or autoimmune diseases
WO1999002188A1 (en) Hen egg yolk antibodies to clostridium difficile antigens and use in therapy for pseudomembranous colitis
US5130128A (en) Use of honey as vaccine
KR100267746B1 (ko) 돼지 대장균 설사증 예방 및 치료용 난황항체를 이용한 경구용 면역제제
Landon et al. Antibody production in the hen
WO1996010420A1 (en) Composition and treatment for hyperimmunization with non heat-killed bacteria
IE75217B1 (en) Method of passive immunization of mammals using bovid antibody and compositions for same
Lee Anti-bacterial activities of chicken egg yolk antibody (IgY) against enteric pathogens